<ul data-eligibleForWebStory="false"><li>Anthem Biosciences plans to invest ₹154 crore towards expanding custom synthesis and fermentation capacities, with a focus on adding new facilities.</li><li>The company aims to increase its custom synthesis capacity at Unit II and introduce new capacity at Unit III, expecting a significant boost in production capabilities by the first half of FY26.</li><li>Post-expansion, the aggregate annual custom synthesis capacity and fermentation capacity are set to rise to 425 kl and 182 kl, respectively, enhancing manufacturing output.</li><li>Anthem Biosciences is preparing for its ₹3,395 crore IPO in mid-July, showcasing strong financial performance with revenue rising to ₹1,844 crore in FY25 and a PAT of ₹451 crore.</li></ul>

IPO-bound Anthem Biosciences to invest ₹154 cr towards expansion of custom synthesis and fermentation capacities

Discover more